RSCM
KNTE
Rock Springs Capital Management’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-405,811
| Closed | -$568K | – | 117 |
|
|
2023
Q3 | $568K | Sell |
405,811
-341,162
| -46% | -$478K | 0.02% | 110 |
|
|
2023
Q2 | $2.26M | Hold |
746,973
| – | – | 0.05% | 105 |
|
|
2023
Q1 | $4.67M | Hold |
746,973
| – | – | 0.11% | 89 |
|
|
2022
Q4 | $4.56M | Hold |
746,973
| – | – | 0.11% | 91 |
|
|
2022
Q3 | $8.93M | Buy |
746,973
+128,589
| +21% | +$1.54M | 0.23% | 83 |
|
|
2022
Q2 | $7.8M | Buy |
618,384
+274,238
| +80% | +$3.46M | 0.23% | 86 |
|
|
2022
Q1 | $3.88M | Buy |
344,146
+4,300
| +1% | +$48.4K | 0.1% | 111 |
|
|
2021
Q4 | $6.02M | Buy |
339,846
+6,860
| +2% | +$122K | 0.14% | 113 |
|
|
2021
Q3 | $7.67M | Buy |
332,986
+1,400
| +0.4% | +$32.2K | 0.16% | 118 |
|
|
2021
Q2 | $7.72M | Buy |
331,586
+5,200
| +2% | +$121K | 0.15% | 124 |
|
|
2021
Q1 | $10.2M | Buy |
326,386
+1,700
| +0.5% | +$53K | 0.22% | 113 |
|
|
2020
Q4 | $12.9M | Buy |
+324,686
| New | +$12.9M | 0.27% | 101 |
|